Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Bronchiectasis | Research

PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model

Authors: Runming Wang, Wenya Li, Haiting Dai, Mingli Zhu, Lingyu Li, Guohui Si, Yilina Bai, Hanyu Wu, Xiaoxiang Hu, Yiming Xing

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent genetic disorder, mainly characterized by the development of renal cysts, as well as various extrarenal manifestations. Previous studies have shown that ADPKD is related to bronchiectasis, while its pathogenic mechanism is unclear. In previous studies, we have generated the PKD1+/− pigs to simulate the progression of cyst formation and physiological alterations similar to those seen in ADPKD patients.

Methods

Phenotypic changes to airway epithelial cell and mesenchymal cell in PKD1+/− pigs were assessed by histological analysis. The molecular mechanisms driving these processes were investigated by using PKD1+/− pig lungs, human mesenchymal cells, and generating PKD1 deficient human epithelial cells.

Results

We identified bronchiectasis in PKD1+/− pigs, which is consistent with the clinical symptoms in ADPKD patients. The deficiency of PKD1 suppressed E-cadherin expression in the airway epithelial barrier, which aggravated invasion and leaded to a perpetuated inflammatory response. During this process, extracellular matrix (ECM) components were altered, which contributed to airway smooth muscle cell phenotype switch from a contractile phenotype to a proliferative phenotype. The effects on smooth muscle cells resulted in airway remodeling and establishment of bronchiectasis.

Conclusion

To our knowledge, the PKD1+/− pig provides the first model recapitulating the pathogenesis of bronchiectasis in ADPKD. The role of PKD1 in airway epithelial suggests a potential target for development of new strategies for the diagnosis and treatment of bronchiectasis.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Boyton RJ, Altmann DM. Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology. Annu Rev Pathol. 2016;11:523–54.CrossRef Boyton RJ, Altmann DM. Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology. Annu Rev Pathol. 2016;11:523–54.CrossRef
3.
go back to reference Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392:880–90.CrossRef Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392:880–90.CrossRef
4.
go back to reference Magis-Escurra C, Reijers MH. Bronchiectasis. BMJ Clin Evid. 2015; 1507. Magis-Escurra C, Reijers MH. Bronchiectasis. BMJ Clin Evid. 2015; 1507.
5.
go back to reference Jain R, et al. Temporal relationship between primary and motile ciliogenesis in airway epithelial cells. Am J Respir Cell Mol Biol. 2010;43:731–9.CrossRef Jain R, et al. Temporal relationship between primary and motile ciliogenesis in airway epithelial cells. Am J Respir Cell Mol Biol. 2010;43:731–9.CrossRef
6.
go back to reference Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919–35.CrossRef Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919–35.CrossRef
7.
go back to reference Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–37.CrossRef Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–37.CrossRef
8.
go back to reference Li LX, et al. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol. 2022;323(2):F227–42.CrossRef Li LX, et al. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol. 2022;323(2):F227–42.CrossRef
9.
go back to reference Driscoll JA, et al. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest. 2008;133:1181–8.CrossRef Driscoll JA, et al. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest. 2008;133:1181–8.CrossRef
10.
go back to reference Barbarino M, et al. PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach. J Cell Mol Med. 2020;24(10):5565–77.CrossRef Barbarino M, et al. PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach. J Cell Mol Med. 2020;24(10):5565–77.CrossRef
11.
go back to reference Cochetti G, et al. Role of miRNAs in prostate cancer: Do we really know everything? Urol Oncol. 2020;38(7):623–35.CrossRef Cochetti G, et al. Role of miRNAs in prostate cancer: Do we really know everything? Urol Oncol. 2020;38(7):623–35.CrossRef
12.
go back to reference Lapa e Silva JR, et al. Immunopathology of experimental bronchiectasis. Am J Respir Cell Mol Biol. 1989;1:297–304.CrossRef Lapa e Silva JR, et al. Immunopathology of experimental bronchiectasis. Am J Respir Cell Mol Biol. 1989;1:297–304.CrossRef
13.
go back to reference Gilley SK, et al. Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways. Am J Physiol Lung Cell Mol Physiol. 2014;306:L162–9.CrossRef Gilley SK, et al. Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways. Am J Physiol Lung Cell Mol Physiol. 2014;306:L162–9.CrossRef
14.
go back to reference Chalmers JD, Loebinger M, Aliberti S. Challenges in the development of new therapies for bronchiectasis. Expert Opin Pharmacother. 2015;16:833–50.CrossRef Chalmers JD, Loebinger M, Aliberti S. Challenges in the development of new therapies for bronchiectasis. Expert Opin Pharmacother. 2015;16:833–50.CrossRef
15.
go back to reference Heinritz SN, Mosenthin R, Weiss E. Use of pigs as a potential model for research into dietary modulation of the human gut microbiota. Nutr Res Rev. 2013;26:191–209.CrossRef Heinritz SN, Mosenthin R, Weiss E. Use of pigs as a potential model for research into dietary modulation of the human gut microbiota. Nutr Res Rev. 2013;26:191–209.CrossRef
16.
go back to reference Wang R, et al. The effects of intrinsic apoptosis on cystogenesis in PKD1-deficient ADPKD pig model. Gene. 2021;798:145792.CrossRef Wang R, et al. The effects of intrinsic apoptosis on cystogenesis in PKD1-deficient ADPKD pig model. Gene. 2021;798:145792.CrossRef
17.
go back to reference Wu J, et al. Characterization of primary cilia in human airway smooth muscle cells. Chest. 2009;136:561–70.CrossRef Wu J, et al. Characterization of primary cilia in human airway smooth muscle cells. Chest. 2009;136:561–70.CrossRef
18.
go back to reference Lu CJ, et al. Non-random distribution and sensory functions of primary cilia in vascular smooth muscle cells. Kidney Blood Press Res. 2008;31:171–84.CrossRef Lu CJ, et al. Non-random distribution and sensory functions of primary cilia in vascular smooth muscle cells. Kidney Blood Press Res. 2008;31:171–84.CrossRef
19.
go back to reference You Y, et al. Role of f-box factor foxj1 in differentiation of ciliated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L650-7.CrossRef You Y, et al. Role of f-box factor foxj1 in differentiation of ciliated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L650-7.CrossRef
20.
go back to reference Moua T, et al. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS ONE. 2014;9:e93674.CrossRef Moua T, et al. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS ONE. 2014;9:e93674.CrossRef
21.
go back to reference Saleh AD, et al. The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017;127:33–9.CrossRef Saleh AD, et al. The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017;127:33–9.CrossRef
22.
go back to reference Ansari AW, et al. CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol. 2011;41:3412–8.CrossRef Ansari AW, et al. CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol. 2011;41:3412–8.CrossRef
23.
go back to reference Rozycki HJ, Zhao W. nterleukins for the paediatric pulmonologist. Paediatr Respir Rev. 2014;I 15:56–68. Rozycki HJ, Zhao W. nterleukins for the paediatric pulmonologist. Paediatr Respir Rev. 2014;I 15:56–68.
24.
go back to reference 21. Nedoszytko B, et al. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatol Alergol. 2014; 31: 84–91. 21. Nedoszytko B, et al. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatol Alergol. 2014; 31: 84–91.
25.
go back to reference Zelova H, Hosek J. TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62:641–51.CrossRef Zelova H, Hosek J. TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62:641–51.CrossRef
26.
go back to reference Aghapour M, et al. Airway Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease: Role of Cigarette Smoke Exposure. Am J Respir Cell Mol Biol. 2018;58:157–69.CrossRef Aghapour M, et al. Airway Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease: Role of Cigarette Smoke Exposure. Am J Respir Cell Mol Biol. 2018;58:157–69.CrossRef
27.
go back to reference Xiao C, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128:549–56.CrossRef Xiao C, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128:549–56.CrossRef
28.
go back to reference Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778:660–9.CrossRef Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778:660–9.CrossRef
29.
go back to reference Nasreen N, et al. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling. Am J Physiol Cell Physiol. 2014;306:C1154–66.CrossRef Nasreen N, et al. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling. Am J Physiol Cell Physiol. 2014;306:C1154–66.CrossRef
30.
go back to reference Kanemaru K, et al. Phospholipase Cdelta1 regulates p38 MAPK activity and skin barrier integrity. Cell Death Differ. 2017;24:1079–90.CrossRef Kanemaru K, et al. Phospholipase Cdelta1 regulates p38 MAPK activity and skin barrier integrity. Cell Death Differ. 2017;24:1079–90.CrossRef
31.
go back to reference Halayko AJ, Tran T, Gosens R. Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins. Proc Am Thorac Soc. 2008;5:80–8.CrossRef Halayko AJ, Tran T, Gosens R. Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins. Proc Am Thorac Soc. 2008;5:80–8.CrossRef
32.
go back to reference Hirota JA, et al. Airway smooth muscle in asthma: phenotype plasticity and function. Pulm Pharmacol Ther. 2009;22:370–8.CrossRef Hirota JA, et al. Airway smooth muscle in asthma: phenotype plasticity and function. Pulm Pharmacol Ther. 2009;22:370–8.CrossRef
33.
go back to reference Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144:1026–32.CrossRef Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144:1026–32.CrossRef
34.
go back to reference Lee SJ, et al. Osteopontin plays a key role in vascular smooth muscle cell proliferation via EGFR-mediated activation of AP-1 and C/EBPbeta pathways. Pharmacol Res. 2016;108:1–8.CrossRef Lee SJ, et al. Osteopontin plays a key role in vascular smooth muscle cell proliferation via EGFR-mediated activation of AP-1 and C/EBPbeta pathways. Pharmacol Res. 2016;108:1–8.CrossRef
35.
go back to reference Feng J, et al. Aortic dissection is associated with reduced polycystin-1 expression, an abnormality that leads to increased ERK phosphorylation in vascular smooth muscle cells. Eur J Histochem. 2016;60:2711. Feng J, et al. Aortic dissection is associated with reduced polycystin-1 expression, an abnormality that leads to increased ERK phosphorylation in vascular smooth muscle cells. Eur J Histochem. 2016;60:2711.
36.
go back to reference Orr AW, et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2009;29:225–31.CrossRef Orr AW, et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2009;29:225–31.CrossRef
37.
go back to reference Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;134:509–20.CrossRef Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;134:509–20.CrossRef
38.
go back to reference Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 2007;127:2525–32.CrossRef Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 2007;127:2525–32.CrossRef
39.
go back to reference Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Investig. 1999;104:1459–68.CrossRef Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Investig. 1999;104:1459–68.CrossRef
40.
go back to reference Roitbak T, et al. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell. 2004;15:1334–46.CrossRef Roitbak T, et al. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell. 2004;15:1334–46.CrossRef
41.
go back to reference Hirst SJ. Regulation of airway smooth muscle cell immunomodulatory function: role in asthma. Respir Physiol Neurobiol. 2003;137:309–26.CrossRef Hirst SJ. Regulation of airway smooth muscle cell immunomodulatory function: role in asthma. Respir Physiol Neurobiol. 2003;137:309–26.CrossRef
42.
go back to reference Black JL, Burgess JK, Johnson PR. Airway smooth muscle–its relationship to the extracellular matrix. Respir Physiol Neurobiol. 2003;137:339–46.CrossRef Black JL, Burgess JK, Johnson PR. Airway smooth muscle–its relationship to the extracellular matrix. Respir Physiol Neurobiol. 2003;137:339–46.CrossRef
43.
go back to reference Hassane S, et al. Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension. Lab Invest. 2011;91:24–32.CrossRef Hassane S, et al. Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension. Lab Invest. 2011;91:24–32.CrossRef
Metadata
Title
PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model
Authors
Runming Wang
Wenya Li
Haiting Dai
Mingli Zhu
Lingyu Li
Guohui Si
Yilina Bai
Hanyu Wu
Xiaoxiang Hu
Yiming Xing
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Bronchiectasis
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02214-3

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine